Latest News / AZD9291 NewsStream Add Bookmark

Latest articles for AZD9291, as of Sat Jul 26.Want Email Updates? Just use the 'Daily Updates' box on the right!. Below that is a more extensive toolbox that allows you to filter and triage these articles.
Coloured tags show you key topics (e.g. Indications, Drugs, Targets, Companies) also mentioned in the article. Click a tag to see its own NewsStream, or the '' link to create a NewsStream that specifically mentions the two topics together.


 
Study To Assess The Effect Of Rifampicin On Blood Levels And Safety Of AZD9291, In Patients With Egfrm+ Nsclc

ClinicalTrials.gov Trial Updates Record#NCT02197247 [Sponsor:AstraZene...  (2 days ago)

Clinical Trial: Expand | View [This Window] [New Window]
 
Study To Assess The Effect Of AZD9291 On The Blood Levels Of Simvastatin In Patients With Egfrm+ Nsclc

ClinicalTrials.gov Trial Updates Record#NCT02197234 [Sponsor:AstraZene...  (2 days ago)

Clinical Trial: Expand | View [This Window] [New Window]
 
Study To Determine The Effect Of Food On The Blood Levels Of AZD9291 Following Oral Dosing Of A Tablet Formulation In Patients With NON-Small Cell Lung Cancer

ClinicalTrials.gov Trial Updates Record#NCT02163733 [Sponsor:AstraZene...  (39 days ago)

Clinical Trial: Expand | View [This Window] [New Window]
 
Investigational Drug AZD9291 Shows Clinical Responses In Patients With ... - Marketwatch

Drug Web Reports  (44 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
Astrazeneca Shows Promising Results Of AZD9291 And MEDI4736 Cancer ... - Tech Times

Drug Web Reports  (50 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
Clovis Stabilizes After Big ASCO-Related Crash

Biomed Reports News  (50 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
AZD9291, An Irreversible Egfr Tki, Overcomes T790m-Mediated Resistance To Egfr Inhibitors In Lung Cancer

Cross DA et al Cancer Discov. 2014 Jun 3. pii: CD-14-0337.  (50 days ago)

Publication: Expand | View [This Window] [New Window]
 
 
Investigational Drug AZD9291 Shows Clinical Responses In Patients With ... - Canada Newswire (Press Release)

Drug Web Reports  (52 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
At Asco, NEXT-Gen Egfr Inhibitors Show Early Promise In Lung Cancer Patients With T790m Mutations

GenomeWebPgx  (54 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
Clovis Oncology's CO-1686 Demonstrates Compelling Clinical Activity And ... - Fiercebiotech

Drug Web Reports  (55 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
Investigational Drug AZD9291 Shows Clinical Responses In Patients With ... - Pr Newswire Uk (Press Release)

Drug Web Reports  (55 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
Clovis Oncology's CO-1686 Demonstrates Compelling Clinical Activity And ... - Business Wire (Press Release)

Drug Web Reports  (55 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
Astrazeneca Rejects Raised Pfizer Bid; Stock Falls Azn Pfe - Investor's Business Daily

Drug Web Reports  (67 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
Marginal Growth In R&D Spending By International Pharma Giants In Q1 - Pharmabiz.Com

Drug Web Reports  (68 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
Astrazeneca's Lung Cancer AZD9291 Shrinks Tumor IN 50 Percent Of Patients ... - Tech Times

Drug Web Reports  (71 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
Astrazeneca Drug Shrinks Lung Cancers Typically Hardened By Genetic Mutation - Thestreet.Com

Drug Web Reports  (72 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
Astrazeneca Net Dips BY 36% In Q1 To $506 Million - Pharmabiz.Com

Drug Web Reports  (89 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
Astrazeneca Posts First Quarter Results - Cambridge Network

Drug Web Reports  (91 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
Astrazeneca Net Dips BY 36% In Q1 To $506 Million - Pharmabiz.Com

Drug Web Reports  (91 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
Astrazeneca's Ceo Discusses Q1 2014 Results - Earnings Call Transcript - Seeking Alpha

Drug Web Reports  (92 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
Astrazeneca Reports On Continued Momentum - Cambridge News

Drug Web Reports  (92 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
Astrazeneca Continues To Chop Back, Spotlights IMMUNO-Oncology Phiii - Fiercebiotech

Drug Web Reports  (92 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
 
Potential New Drug For Some Patients With TREATMENT-Resistant Lung Cancer

All latest news news from MedicalXpress  (278 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
Astrazeneca Ceo Celebrates 1st Anniversary With Promising Lung Cancer Data

FierceBiotech  (298 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
With Promising Results, Astrazeneca Targets Mutated Lung Cancer And Rival ... - Thestreet.Com

Drug Web Reports  (299 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
With Promising Results, Astrazeneca Targets Mutated Lung Cancer And Rival Clovis Drug

TheStreet.com  (299 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
Tolerability,Pharmacokinetics&Preliminary Antitumour Activity Of Ascending Doses Of AZD9291 In Patients With Advanced Non Small Cell Lungcancer Who Have Progressed Following Prior Therapy With An Epidermal Growth Factorreceptortyrosinekinaseinhibatoragent

ClinicalTrials.gov Trial Updates Record#NCT01802632 [Sponsor:AstraZene...  (512 days ago)

Clinical Trial: Expand | View [This Window] [New Window]


No More Articles Available


Topic Activity [last 90 days]

Please wait... If the chart does not appear, try updating your browser, ensuring javasript is turned turned on

  Daily Alerts!

 Get Regular Updates By:  Email or RSS

[Need Help With RSS?]
 About This Topic  Data Mining Tools  My Recent Topics  Quick Help

Sponsored Links


Interested in sponsoring our site or advertising with us? Be a part of SciBites growing success. Contact Us Today.



View as RDF